论文部分内容阅读
目的探讨极化液心衰合剂治疗顽固性心力衰竭患者的治疗效果。方法我院急诊室2010年2月—2012年2月收治的顽固性心力衰竭患者100例,将其随机分为观察组和对照组,各50例。两组患者进行常规的利尿剂、血管扩张剂、强心剂等心力衰竭的基础治疗,观察组患者在常规治疗的基础上给予极化液心衰合剂治疗,10d为1个疗程,2个疗程结束后,比较两组患者的治疗结果。结果治疗后两组左室射血分数(LVEF)、收缩压(SBP)、血氧饱和度(SaO2)、每搏量(SV)、心率以及尿量比较,差异均有统计学意义(P<0.05);观察组总有效率为92%,对照组总有效率为68%,两组比较差异有统计学意义(P<0.05);两组患者均未出现严重的不良反应。结论极化液心衰合剂治疗顽固性心力衰竭疗效显著、不良反应少,值得临床推广应用。
Objective To investigate the therapeutic effect of the Polaroidis syndrome in patients with refractory heart failure. Methods One hundred patients with refractory heart failure admitted to our emergency department from February 2010 to February 2012 were randomly divided into observation group and control group, with 50 cases in each group. The patients in the two groups were given basic treatment of heart failure such as diuretics, vasodilators and cardiotonics. The patients in the observation group were treated with POCF on the basis of routine treatment. One course of treatment was given after 10 days. After two courses of treatment , Comparing the results of the treatment of two groups of patients. Results After treatment, the differences of LVEF, SBP, SaO2, SV, heart rate and urine volume were statistically significant (P < 0.05). The total effective rate was 92% in the observation group and 68% in the control group, with significant difference between the two groups (P <0.05). No serious adverse reactions occurred in both groups. Conclusions Polaroidis syndrome is effective in treatment of refractory heart failure with less adverse reactions and is worthy of clinical application.